COVID-19 among children and adolescents].

Children and adolescents infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are usually asymptomatic or have mild coronavirus disease (COVID-19) with low rates of hospitalization and death. Multisystem inflammatory syndrome in children (MIS-C) is a rare and severe complication of SARS-CoV-2 infection. This paper reviews an excerpt of the literature on disease burden and complications following COVID-19 in children and adolescents aged 0-17 years, in addition to the effects and adverse drug reactions of BNT162b2 and mRNA-1273 vaccinations among children and adolescents aged 5-17 years.

Citation

Astrid Blicher Schelde, Katrine Finderup Nielsen, Ulrikka Nygaard, Marie-Louise von Linstow, Laura Espenhain, Anders Koch. COVID-19 among children and adolescents]. Ugeskrift for laeger. 2022 Feb 28;184(9)

Mesh Tags

Substances

PMID: 35244020

search → result